Compare AbbVie Inc (ABBV) vs Ford Motor Company (F) Price & Performance

AbbVie (ABBV) trades at $247.91, up 0.76% today, with a bullish technical signal and strong analyst support. Recent earnings beats and a 70.73% buy consensus highlight robust fundamentals, driven by Skyrizi and Rinvoq growth offsetting Humira declines. Positive news includes Phase 2 ovarian cancer data and institutional stake increases, reinforcing momentum.

Outlook remains positive with a $278.69 price target, though risks include patent cliffs and debt levels. Revenue growth and dividend stability offer appeal, but investors should monitor competitive pressures and regulatory developments for sustained performance.

Ford Motor Company (F) trades at $14.015, up 0.25% on the day, with a bearish technical signal and mixed earnings history including a recent Q3 2026 miss. The company reported a net loss of $8.18 billion for 2025, with negative profit margins, but maintains strong operating cash flow of $21.28 billion. Recent news highlights the upcoming affordable Fathom EV truck priced around $28,000, targeting market share gains amid high vehicle prices.

The outlook is cautious; while analyst consensus is a Buy with a $16.18 price target, fundamental weaknesses like negative ROE and net income margin pose risks. The EV transition and competitive pressures are key challenges, but the dividend yield and cash flow stability offer some investor appeal. Execution on new models like the Fathom is critical for a turnaround.